Page 2 - Tellbio Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 10, 2021
Closes $5 million Series A financing
Appoints Pritesh J. Gandhi, PharmD, as Chief Executive Officer and Annie Partisano, PharmD, MS, as Senior Vice President and Head of Operations
Announces exclusive license of TellDx platform to Genetron Holdings Limited for China
Secures Deployment of TellDx at ARUP Laboratories, Inc
BEVERLY, Mass., May 10, 2021 (GLOBE NEWSWIRE)
TellBio, Inc., a development stage biotechnology company focused on revolutionizing the detection and treatment of cancer through its unique and proprietary circulating tumor cell (CTC) technology, TellDx, and complementary therapeutics platform, TellRx, today announced the closing of a $5 million Series A financing. Concurrent with the close, the Company announced the appointments of Pritesh J. Gandhi, PharmD, as Chief Executive Officer (CEO) and Annie Partisano, PharmD, MS, as Senior Vice President and Head of Operations; an exclusive license of the TellDx platf ....

United States , University Of Massachusetts Medical School , Ryo Imai , Sanofi Genzyme , Ravi Kapur , David Ting , Richard Peters , Priteshj Gandhi , Mehmet Toner , Andy Theurer , Shyamala Maheswaran , Annie Partisano , Daniel Haber , University Of Utah , Alnylam Pharmaceuticals , Genetron Holdings , Institute For Clinical , Genetron Holdings Limited , Kiniksa Pharmaceuticals , Affairs At Boehringer Ingelheim , Massachusetts College Of Pharmacy , Laboratories Inc , National Foundation For Cancer Research , Tellbio Inc , Department Of Pathology , Company As Senior Vice ,